Aidence

Aidence develops AI-powered clinical applications that empower healthcare and pharmaceutical professionals in the lung cancer pathway. Their flagship product, Veye Lung Nodules, is a CE-certified deep learning solution for automated detection, quantification, and tracking of pulmonary nodules on chest CTs. They also offer Veye Reporting for standardized quality reporting. The company's mission is to deliver faster, more precise diagnostics and treatments, improving early detection and treatment response assessment for lung cancer patients.